Comments on theoretical bases for the role of erythrocyte sedimentation rate, plasma viscosity and zeta sedimentation ratio in clinical medicine1

2016 ◽  
Vol 1 (5-6) ◽  
pp. 585-586
Author(s):  
Megha Singh
Rheumatology ◽  
2014 ◽  
Vol 53 (suppl_1) ◽  
pp. i188-i188
Author(s):  
Chitra Salem-Ramakumaran ◽  
Sarah Donaldson ◽  
Elizabeth M. A. Hensor ◽  
Aruna Chakrabarty ◽  
Ann W. Morgan ◽  
...  

2019 ◽  
Vol 91 (5) ◽  
pp. 26-33
Author(s):  
A S Avdeeva ◽  
M V Cherkasova ◽  
D A Kusevich ◽  
V V Rybakova ◽  
A S Artyuhov ◽  
...  

Aim: to evaluate the role of laboratory biomarkers in monitoring effectiveness of rituximab (RTM) biosimilar therapy in a total dose of 1200 mg. Materials and methods. 20 patients (pts) with rheumatoid arthritis (RA) (18 woman, mean age 61.5(54-66.5) years, mean disease duration 39.5(20-84) months, mean DAS28 5.6(4.9-6.8)) received two intravenous RTM biosimilar infusions (600 mg №2) in combination with DMARDs and glucocorticoids. Laboratory biomarkers were assessed at baseline and weeks 12 and 24 after the first infusion of RTX. Results. RTM biosimilar induced decreases in DAS28, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) at week 12 and 24, p


Sign in / Sign up

Export Citation Format

Share Document